Skip to content
HowShorted

Ampio Pharmaceuticals Inc. short interest in 2020

In 2020, Ampio Pharmaceuticals Inc.'s disclosed short interest ran from 7.27% of shares outstanding on 15 Jan 2020 to 11.73% on 31 Dec 2020, a change of +4.46 percentage points. The year's high was 11.73% on 31 Dec 2020 and its low 6.67% on 31 Mar 2020, averaging 8.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.22 days on 30 Oct 2020. Full history: Ampio Pharmaceuticals Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Ampio Pharmaceuticals Inc. in 2020

2020 in figures

Start of year
7.27% (15 Jan 2020)
End of year
11.73% (31 Dec 2020)
Change
+4.46 pp
High
11.73% (31 Dec 2020)
Low
6.67% (31 Mar 2020)
Average
8.64%
Highest days to cover
21.22 (30 Oct 2020)
SEC filings marked
6

Every report in 2020

Ampio Pharmaceuticals Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20207.27%6.13
31 Jan 20208.03%11.39
14 Feb 20208.60%17.70
28 Feb 20207.80%13.2010-K filed
13 Mar 20207.28%16.13
31 Mar 20206.67%6.76
15 Apr 20206.93%3.90
30 Apr 20207.14%6.00results (8-K)
15 May 20207.43%11.0510-Q filed
29 May 20207.72%7.93
15 Jun 20207.39%12.23
30 Jun 20207.87%2.16
15 Jul 20207.94%6.13
31 Jul 20207.92%2.8210-Q filed
14 Aug 20208.71%6.41
31 Aug 20208.98%7.47
15 Sep 20209.06%4.41
30 Sep 202010.12%2.35
15 Oct 202010.57%15.39
30 Oct 202010.87%21.22
13 Nov 202010.59%17.8510-Q filed, results (8-K)
30 Nov 202010.46%15.16
15 Dec 202010.18%3.05
31 Dec 202011.73%1.22

See also: Ampio Pharmaceuticals Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.